Thursday, 19 October 2017
Latest news
Main » Understanding the Financial Health of Abbott Laboratories (NYSE:ABT)

Understanding the Financial Health of Abbott Laboratories (NYSE:ABT)

13 October 2017

The stock increased 1.34% or $0.73 during the last trading session, reaching $55.4. Abbott Laboratories (NYSE:ABT) has risen 15.90% since October 11, 2016 and is uptrending. It has underperformed by 27.05% the S&P500. Fruth Inv Mngmt owns 11,716 shares. Its down 0.35% from 9.87M shares previously.

Among 9 analysts covering CGI Group (NYSE:GIB), 6 have Buy rating, 1 Sell and 2 Hold. The stock traded within a range of $54.53 and $55.43. It has outperformed by 4.93% the S&P500.

The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.00 for ABT and 2.30 for MDT, which implies that analysts are more bullish on the outlook for MDT. Therefore 50% are positive. As per Wednesday, July 12, the company rating was initiated by Nomura. The rating was downgraded by BMO Capital Markets to "Market Perform" on Tuesday, March 14. Cowen & Co maintained Abbott Laboratories (NYSE:ABT) on Friday, September 22 with "Buy" rating. The firm has "Hold" rating by Oppenheimer given on Wednesday, June 14. Jefferies downgraded Cheesecake Factory Inc (NASDAQ:CAKE) on Wednesday, January 4 to "Underperform" rating. Rhumbline Advisers, a Massachusetts-based fund reported 56,264 shares. The stock has a market cap of $94.59 billion, a PE ratio of 76.25 and a beta of 1.06.

Liquidity and leverage ratios provide insight into the financial health of a company, and allow investors to determine the likelihood that the company will be able to continue operating as a going concern. It has a 11.79 P/E ratio. The Company's divisions include The Cheesecake Factory restaurants, and other.

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $101,964 activity. PITTAWAY DAVID BRUCE had bought 400 shares worth $23,288. Also, insider Hubert L. Allen sold 4,600 shares of the stock in a transaction dated Tuesday, July 25th. Eqis Capital Management Inc acquired 12,346 shares as Open Text Corp (OTEX)'s stock declined 3.85%. Voya Invest Llc reported 1.05 million shares stake. Tokio Marine Asset holds 0.13% or 18,213 shares. Rodgers Brothers Incorporated holds 118,124 shares or 2.12% of its portfolio. Mycio Wealth Prtnrs Ltd Liability Co has 0.04% invested in Abbott Laboratories (NYSE:ABT). Rothschild Asset Mgmt stated it has 152,694 shares. The Bank's business consists primarily of accepting deposits from the general public, small businesses and municipalities, and investing those deposits, together with funds generated from activities and borrowings, in one- to four-family residential mortgage loans, commercial real estate loans, multi-family real estate loans, home equity lines of credit, indirect automobile loans, commercial business loans, construction loans and investment securities. 98,490 were reported by Manufacturers Life Insurance The. Clovis Oncology Inc (NASDAQ:CLVS) was raised too.

Analysts often look at short interest, or the percentage of a company's float now being shorted by investors, to aid in their outlook for a particular stock. Cwm reported 59,076 shares. The Eqis Capital Management Inc holds 19,975 shares with $630,000 value, up from 7,629 last quarter. Huntington Bancorp reported 641 shares. About 207,154 shares traded. Alley Comm Lc owns 112,703 shares for 2.07% of their portfolio.

Investors sentiment decreased to 1.4 in 2017 Q2. It is negative, as 69 investors sold ABT shares while 545 reduced holdings. 102 funds opened positions while 441 raised stakes.

The market cap of 95.14B for Abbott Laboratories in today's market indicated its current strength, making the company's shares a lucrative one. Finally, Swiss National Bank grew its stake in shares of Abbott Laboratories by 45.3% during the 1st quarter. The EPS growth for the past five (5) years shows a value of 0.00%, whilst the EPS value for the next five (5) years shows a figure of 11.29%. An ROI of 6.70% for Abbott Laboratories evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments. Diamond Offshore Drilling Inc. had 68 analyst reports since August 5, 2015 according to SRatingsIntel. Glynn Cap Mngmt Ltd Limited Liability Company has invested 0.27% of its portfolio in Abbott Laboratories (NYSE:ABT). Abbott Laboratories has a 52 week low of $37.38 and a 52 week high of $55.43. City Holdings, a West Virginia-based fund reported 51,683 shares. Pure Fin Advsrs Inc holds 0.15% or 11,315 shares in its portfolio. Sei Invests reported 539,622 shares.

Abbott Laboratories (ABT) reported earning per shares for the quarter ending Oct 18 BMO at 0.62, whereas, 16 number of analysts estimated the mean EPS at 0.73. Abbott Laboratories experienced its Day High at -0.23%, with its Day Low of 14.43%. Heritage Trust Co increased its holdings in shares of Abbott Laboratories by 10.1% during the 2nd quarter. Therefore 58% are positive. Abbott Laboratories's revenue for the quarter was up 24.5% on a year-over-year basis. The company was maintained on Monday, May 2 by Goldman Sachs. The firm earned "Buy" rating on Friday, July 21 by Deutsche Bank.

Abbott Laboratories (ABT) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The company was maintained on Saturday, August 29 by Deutsche Bank. The rating was maintained by BTIG Research on Saturday, August 29 with "Buy". Macquarie Research initiated the shares of GIB in report on Tuesday, September 27 with "Neutral" rating. The firm has "Overweight" rating given on Thursday, April 20 by Barclays Capital. Wells Fargo & Company reaffirmed an "outperform" rating and issued a $54.00 price objective (up from $47.50) on shares of Abbott Laboratories in a research report on Friday, June 30th.